ablation post

Ablation Market Forecasts Various sources forecast growth in the RF Ablation devices market to be anywhere from 7-12% over the next five years to more than $22.5 Billion (US) dollars by 2024.  Though market predictions vary by source, nearly all mention the following considerations driving growth. Increase in demand for minimally invasive (MI) surgery options…

Read More

OsteoCool from Medtronic uses both AdvantageRF and AdvantageFD platforms from Energize Medical. The OsteoCool technology recently won further indications from FDA, as originally reported in MassDevice: Medtronic (NYSE:MDT) said today that it won an expanded indication from the FDA for its OsteoCool RF ablation device for palliative treatment of metastases in all bony anatomy. The OsteoCool…

Read More